Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KAT6B is a histone acetyltransferase enzyme that plays a critical role in regulating gene expression by acetylating lysine residues on histone H3. This modification influences chromatin structure and impacts various cellular processes, including development, cell cycle progression, and DNA repair. It is implicated in developmental disorders and cancer, acting as both an oncogene and tumor suppressor depending on the cellular context, and is considered a potential therapeutic target.
Histone acetylation, affecting gene expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on K(lysine) acetyltransferase 6B (KAT6B).